7.04
price down icon3.03%   -0.22
after-market 시간 외 거래: 7.39 0.35 +4.97%
loading
전일 마감가:
$7.26
열려 있는:
$7.29
하루 거래량:
94,268
Relative Volume:
0.44
시가총액:
$75.01M
수익:
$1.54M
순이익/손실:
$-38.70M
주가수익비율:
-1.5075
EPS:
-4.67
순현금흐름:
$-36.86M
1주 성능:
+14.85%
1개월 성능:
+21.38%
6개월 성능:
-59.89%
1년 성능:
-83.62%
1일 변동 폭
Value
$6.76
$7.4378
1주일 범위
Value
$6.25
$7.44
52주 변동 폭
Value
$4.64
$61.90

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile

Name
명칭
Corbus Pharmaceuticals Holdings Inc
Name
전화
617-963-0103
Name
주소
500 RIVER RIDGE DRIVE, NORWOOD, MA
Name
직원
28
Name
트위터
@corbuspharma
Name
다음 수익 날짜
2024-11-05
Name
최신 SEC 제출 서류
Name
CRBP's Discussions on Twitter

CRBP을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CRBP
Corbus Pharmaceuticals Holdings Inc
7.04 75.01M 1.54M -38.70M -36.86M -4.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.16 111.66B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
571.36 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
532.27 38.04B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
267.55 36.06B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ONC
Beigene Ltd Adr
219.95 25.10B 3.81B -644.79M -669.77M -6.24

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-02-28 개시 William Blair Outperform
2024-12-02 개시 Piper Sandler Overweight
2024-07-30 개시 Wedbush Outperform
2024-07-22 재개 H.C. Wainwright Buy
2024-06-26 개시 B. Riley Securities Buy
2024-06-03 재확인 Oppenheimer Outperform
2024-05-13 개시 RBC Capital Mkts Outperform
2024-03-06 업그레이드 Jefferies Hold → Buy
2020-09-08 다운그레이드 BTIG Research Buy → Neutral
2020-09-08 다운그레이드 Jefferies Buy → Hold
2020-09-08 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2020-09-08 다운그레이드 ROTH Capital Buy → Neutral
2020-07-07 개시 ROTH Capital Buy
2020-06-17 개시 BTIG Research Buy
2020-03-26 개시 Nomura Buy
2019-04-05 개시 Jefferies Buy
2019-03-20 개시 Oppenheimer Outperform
2019-01-11 재확인 Cantor Fitzgerald Overweight
2018-12-26 개시 H.C. Wainwright Buy
2018-12-07 개시 RBC Capital Mkts Outperform
2018-10-24 개시 B. Riley FBR Buy
2018-01-19 개시 Raymond James Outperform
2017-12-14 재확인 Cantor Fitzgerald Overweight
2017-11-08 재확인 Noble Financial Buy
2017-09-29 재개 Noble Financial Buy
2017-03-30 재확인 Cantor Fitzgerald Overweight
2016-11-15 재확인 JMP Securities Mkt Outperform
2016-11-11 재확인 Noble Financial Buy
모두보기

Corbus Pharmaceuticals Holdings Inc 주식(CRBP)의 최신 뉴스

pulisher
May 13, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Sold by Barclays PLC - Defense World

May 13, 2025
pulisher
May 13, 2025

Wells Fargo & Company MN Has $76,000 Holdings in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

May 13, 2025
pulisher
May 12, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Sold by Tower Research Capital LLC TRC - Defense World

May 12, 2025
pulisher
May 10, 2025

Oppenheimer Cuts Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target to $56.00 - Defense World

May 10, 2025
pulisher
May 10, 2025

B. Riley Expects Reduced Earnings for Corbus Pharmaceuticals - Defense World

May 10, 2025
pulisher
May 10, 2025

HC Wainwright Cuts Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target to $40.00 - Defense World

May 10, 2025
pulisher
May 10, 2025

Wedbush Expects Weaker Earnings for Corbus Pharmaceuticals - Defense World

May 10, 2025
pulisher
May 09, 2025

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch

May 09, 2025
pulisher
May 09, 2025

Royal Bank of Canada Has Lowered Expectations for Corbus Pharmaceuticals (NASDAQ:CRBP) Stock Price - Defense World

May 09, 2025
pulisher
May 08, 2025

Corbus Pharmaceuticals to Present at the 2025 RBC Capital Markets Global Healthcare Conference - GlobeNewswire

May 08, 2025
pulisher
May 08, 2025

Cannabis Stock Tilray Brands Loses 19% in a Month: Time to Sell or Hold? - Zacks Investment Research

May 08, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

May 07, 2025
pulisher
May 07, 2025

CRBP: RBC Capital Lowers Price Target, Maintains Outperform Rati - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Oppenheimer Lowers Price Target for Corbus Pharmaceuticals (CRBP) | CRBP Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals (CRBP) Target Price Reduced by Analyst | CRBP Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals (CRBP) Target Price Adjusted by RBC Capital | CRBP Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

CRBP: HC Wainwright & Co. Lowers Price Target for Corbus Pharmaceuticals | CRBP Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Oppenheimer Adjusts Price Target for Corbus Pharmaceuticals (CRBP) | CRBP Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

RBC Cuts Price Target on Corbus Pharmaceuticals Holdings to $58 From $65, Keeps Outperform, Speculative Risk - marketscreener.com

May 07, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals (CRBP) Sees Price Target Reduction | CRBP Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals: Q1 Earnings Snapshot - CTPost

May 07, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides a Corporate Update - GlobeNewswire

May 07, 2025
pulisher
May 07, 2025

Corbus Pharmaceuticals Advances Clinical Pipeline Amid Q1 Loss - TipRanks

May 07, 2025
pulisher
May 06, 2025

Corbus Pharmaceuticals (CRBP) Advances Pipeline with Promising E - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Corbus Pharmaceuticals Receives FDA Fast Track Designation - TipRanks

May 06, 2025
pulisher
May 06, 2025

Corbus Pharmaceuticals (CRBP) Advances Pipeline with Promising Early Trial Data | CRBP Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Corbus Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits - Quantisnow

May 06, 2025
pulisher
May 06, 2025

Corbus Pharmaceuticals Secures FDA Fast Track for Cancer Drug as 3 Clinical Programs Hit Key Milestones - Stock Titan

May 06, 2025
pulisher
May 06, 2025

Trading (CRBP) With Integrated Risk Controls - news.stocktradersdaily.com

May 06, 2025
pulisher
May 04, 2025

Corbus Pharmaceuticals (CRBP) to Release Quarterly Earnings on Tuesday - Defense World

May 04, 2025
pulisher
May 02, 2025

Corbus Pharmaceuticals Holdings Inc expected to post a loss of $1.28 a shareEarnings Preview - TradingView

May 02, 2025
pulisher
Apr 29, 2025

3 Unconventional Cannabis Stocks to Watch in 2025 - Zacks Investment Research

Apr 29, 2025
pulisher
Apr 29, 2025

Geode Capital Management LLC Acquires 13,773 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

Apr 29, 2025
pulisher
Apr 28, 2025

Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch

Apr 28, 2025
pulisher
Apr 28, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives $59.13 Average Price Target from Analysts - American Banking and Market News

Apr 28, 2025
pulisher
Apr 26, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 26, 2025
pulisher
Apr 26, 2025

Brokerages Set Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) PT at $59.13 - Defense World

Apr 26, 2025
pulisher
Apr 25, 2025

Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch

Apr 25, 2025
pulisher
Apr 24, 2025

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

Apr 24, 2025
pulisher
Apr 20, 2025

(CRBP) Trading Report - news.stocktradersdaily.com

Apr 20, 2025
pulisher
Apr 18, 2025

We Think Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Can Afford To Drive Business Growth - Yahoo Finance

Apr 18, 2025
pulisher
Apr 18, 2025

Wall Street Analysts See a 764.18% Upside in Corbus Pharmaceuticals (CRBP): Can the Stock Really Move This High? - Yahoo Finance

Apr 18, 2025
pulisher
Apr 07, 2025

CRBP stock touches 52-week low at $4.64 amid sharp annual decline - Investing.com

Apr 07, 2025
pulisher
Apr 07, 2025

CRBP stock touches 52-week low at $4.64 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 04, 2025

Where are the Opportunities in (CRBP) - news.stocktradersdaily.com

Apr 04, 2025
pulisher
Apr 03, 2025

Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Apr 03, 2025

Corbus Pharmaceuticals Holdings Inc (CRBP) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$65.61
price down icon 0.15%
$19.08
price down icon 1.19%
$32.29
price down icon 1.61%
$22.75
price down icon 7.56%
$92.08
price down icon 2.56%
biotechnology ONC
$219.95
price down icon 2.13%
자본화:     |  볼륨(24시간):